Atlas Trials

Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients

Clinical trial NCT02426359 · COMPLETED

Trial details

NCT number
NCT02426359
Sponsor
Qurient Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Moderate to Severe Atopic Dermatitis
Start date
2015-04-01
Primary completion
2016-01-01
Enrollment
57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.